Search

Protein arginylation has been discovered in 1963 as a soluble activity in cell extracts that mediates addition of amino acids to proteins. This discovery was nearly accidental, but due to the persistence of the research team, it has been followed through and led to the emergence of a new field of research. This chapter describes the original discovery of arginylation and the first methods used to demonstrate the existence of this important biological process.

The E. coli aminoacyl transferase (AaT) can be used to transfer a variety of unnatural amino acids, including those with azide or alkyne groups, to the α-amine of a protein with an N-terminal Lys or Arg. Subsequent functionalization through either copper-catalyzed or strain-promoted click reactions can be used to label the protein with fluorophores or biotin. This method can be used to directly detect AaT substrates or in a two-step protocol to detect substrates of the mammalian ATE1 transferase.

The prevalence of non-alcoholic fatty liver disease (NAFLD) increases with aging. However, the mechanism of aging-related NAFLD remains unclear. Herein, we constructed an aging-related hepatic steatosis model and analyzed the differentially expressed proteins (DEPs) in livers from young and old mice using liquid chromatography-mass spectrometry. Five hundred and eighty-eight aging-related DEPs and novel pathways were identified. Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2), the most significantly upregulated protein, promoted poly(ADP-ribose) polymerase 1 (PARP1) activation in aging-related hepatic steatosis. Additionally, mice liver-specific O-GlcNAcase knockout promoted AIMP2 and PARP1 expression. O-GlcNAc transferase (OGT) overexpression and O-GlcNAcase inhibition by genetic or pharmaceutical manipulations increased AIMP2 and PARP1 levels in vitro. Mechanistically, O-GlcNAcylation increased AIMP2 protein stability, leading to its aggregation. Our study reveals O-GlcNAcylated AIMP2 as a novel pathogenic regulator of aging-related hepatic steatosis.

Polyhydroxyalkanoates are attractive alternatives to traditional plastics. However, although polyhydroxybutyrate (PHB) is produced in large quantities by Cupriavidus necator H16, its properties are far from ideal for the manufacture of plastic products. These properties may be improved through its coproduction with 3-hydroxypropionate (3HP), which leads to the formation of the copolymer poly(3-hydroxybutyrate-co-3-hydroxypropionate) (poly(3HB-co-3HP). To achieve this, a pathway was designed to enable C. necator H16 to convert β-alanine to 3HP. The initial low levels of incorporation of 3HP into the copolymer were overcome by the overproduction of the native propionyl-CoA transferase together with PHA synthase from Chromobacterium sp. USM2. Following optimization of 3HP incorporation into the copolymer, the molar fraction of 3HP could be controlled by cultivation in medium containing different concentrations of β-alanine. Between 0 and 80 mol % 3HP could be achieved. Further supplementation with 2 mM cysteine increased the maximum 3HP molar fraction to 89%. Additionally, the effect of deletions of the phaA and phaB1 genes of the phaCAB operon on 3HP molar fraction were investigated. A phaAB1 double knockout resulted in a copolymer containing 91 mol % 3HP without the need for cysteine supplementation.

Biofilms are communities of self-enmeshed bacteria in a matrix of exopolysaccharides. The widely distributed human pathogen and commensal Escherichia coli produces a biofilm matrix composed of phosphoethanolamine (pEtN)-modified cellulose and amyloid protein fibers, termed curli. The addition of pEtN to the cellulose exopolysaccharide is accomplished by the action of the pEtN transferase, BcsG, and is essential for the overall integrity of the biofilm. Here, using the synthetic co-substrates p-nitrophenyl phosphoethanolamine and β-d-cellopentaose, we demonstrate using an in vitro pEtN transferase assay that full activity of the pEtN transferase domain of BcsG from E. coli (EcBcsGΔN) requires Zn2+ binding, a catalytic nucleophile/acid-base arrangement (Ser278/Cys243/His396), disulfide bond formation, and other newly uncovered essential residues. We further confirm that EcBcsGΔN catalysis proceeds by a ping-pong bisubstrate-biproduct reaction mechanism and displays inefficient kinetic behavior (kcat/KM = 1.81 × 10-4 ± 2.81 × 10-5 M-1 s-1), which is typical of exopolysaccharide-modifying enzymes in bacteria. Thus, the results presented, especially with respect to donor binding (as reflected by KM), have importantly broadened our understanding of the substrate profile and catalytic mechanism of this class of enzymes, which may aid in the development of inhibitors targeting BcsG or other characterized members of the pEtN transferase family, including the intrinsic and mobile colistin resistance factors.

O-linked β-N-acetylglucosamine (O-GlcNAc), an important post-translational modification of proteins, plays an essential role in maintaining normal biological activities of organisms. Studies have shown that the disruption of O-GlcNAc homeostasis is closely associated with various human diseases. Therefore, large-scale enrichment and identification of O-GlcNAc proteins is important for exploring diagnostic biomarkers of clinical diseases. O-GlcNAcylation is substoichiometric, and its glycosidic bond is unstable; hence, the enrichment and identification of O-GlcNAc proteins remains a challenge. Recently, metabolic labeling technology with per-O-acetylated unnatural monosaccharides has been introduced to enrich O-GlcNAc proteins or peptides in cells. However, azidosugars can also react with the thiol group of cysteine to form cysteine thiol-azidosugar artificial modification as a byproduct in cell metabolism, which interferes with the identification of O-GlcNAc proteins or peptides. Therefore, the development of a methodology for the specific and complete removal of cysteine thiol-azidosugar artificial modification is necessary. O-Mesitylenesulfonylhydroxylamine (MSH) is an oxidizing and aminating reagent with great potential to oxidatively eliminate the cysteine thiol modification to dehydroalanine. Hence, it is worthwhile to probe whether MSH can eliminate cysteine thiol-azidosugar artificial modification. Two cysteine thiol-azidosugar artificial modifications were synthesized successfully by incubating thiol standard peptides with tetraacetylated N-azidoacetylgalactosamine (Ac4GalNAz) in sodium carbonate buffer (200 mmol/L, pH 10) at 37 ℃ for 90 min. Then, the reaction conditions for MSH oxidative elimination were optimized to completely remove cysteine thiol-azidosugar artificial modification. Sodium phosphate buffer (50 mmol/L, pH 8.0) was selected to protect the O-GlcNAc modification due to its mild nature. After extensive investigation, the optimized reaction conditions were established as 95 ℃ (reaction temperature) and 30 min (reaction time). Both cysteine thiol-azidosugar artificial modifications could be removed completely under these conditions. Furthermore, two azide-labeled O-GlcNAc (N3-O-GlcNAc) peptides were used to assess whether MSH destroyed the O-GlcNAc modification at the same time. The results showed that the two N3-O-GlcNAc peptides were stable after treatment with MSH at 95 ℃ for 30 min. In short, with excess MSH, the N3-O-GlcNAc peptides were stable, but the cysteine thiol-azidosugar artificial modification was exhausted in sodium phosphate buffer (50 mmol/L, pH 8.0) at 95 ℃ for 30 min. Moreover, both O-GlcNAc modification and cysteine thiol-azidosugar artificial modification exist in cell metabolism. This method can not only remove cysteine thiol-azidosugar artificial modification but also ensure the stability of O-GlcNAc modification. There is growing evidence that O-GlcNAcylation mainly occurs in proteins in the cytoplasm and nucleus, and that most O-GlcNAc proteins are involved in important biological signaling pathways. The nuclear and cytoplasmic proteins incubated with Ac4GalNAz in HeLa cells were selected as a model system. After the nuclear and cytoplasmic proteins were digested into peptides, MSH was applied to remove cysteine thiol-azidosugar modification. In addition, 51 peptides for the elimination of the cysteine thiol-azidosugar artificial modification were identified, indicating that MSH can remove the interference of cysteine thiol-azidosugar artificial modification in cell metabolism. Biotin probe and streptavidin dynabeads were subsequently used to label and enrich N3-O-GlcNAz peptides in cell metabolism. Finally, 157 O-GlcNAc peptides attributed to 130 proteins were identified. To better understand the functional roles of O-GlcNAc proteins, gene ontology analysis was performed. Cell component analysis showed that the identified O-GlcNAc proteins were mainly distributed inpostsynaptic density, cytoplasm, and condensed nuclear chromosome. The proteins were mostly involved in biological processes, including cell division, excitatory postsynaptic potential, and microtubule-based movement. The proteins responsible for transferase activity, transferring acyl groups, histone acetyltransferase activity, and microtubule binding were highly enriched, indicating that O-GlcNAc proteins play important roles in cells. In summary, this work developed an approach to enrich O-GlcNAc peptides precisely in metabolic labeling by removing cysteine thiol-azidosugar artificial modification with MSH. This methodology provides a new strategy for the application of metabolic labeling technology with unnatural monosaccharides in glycoproteomics analysis.

Protein prenylation plays a crucial role in plant development and stress response. We report the function of prenyltransferase α-subunit in rice. Protein-protein interactions showed that the farnesyl- transferase (OsPFT)/geranylgeranyltransferase-I (OsPGGT I-α) protein interacted together with OsPFT-β and OsPGGT I-β. The α- and β-subunits of OsPFT formed a heterodimer for the transfer of a farnesyl group from farnesyl pyrophosphate to the CaaX-box-containing peptide N-dansyl-GCVLS. Furthermore, the tissue expression patterns of the OsPFT and OsPGGT I subunits were similar, and these subunits were localized in the cytoplasm and nucleus. Moreover, OsPFT/OsPGGT I-α-deletion homozygous rice mutants had a lethal phenotype, and the heterozygous mutants exhibited reduced pollen viability. These results indicated that prenylation plays an important role in rice development.

Protein lipidation is challenging to analyze on the proteome level. This protocol describes metabolic incorporation of lipid probes and their capture via click chemistry, allowing in-gel fluorescence visualization or mass spectrometry analysis., Protein lipidation is one of the most widespread post-translational modifications (PTMs) found in nature, regulating protein function, structure and subcellular localization. Lipid transferases and their substrate proteins are also attracting increasing interest as drug targets because of their dysregulation in many disease states. However, the inherent hydrophobicity and potential dynamic nature of lipid modifications makes them notoriously challenging to detect by many analytical methods. Chemical proteomics provides a powerful approach to identify and quantify these diverse protein modifications by combining bespoke chemical tools for lipidated protein enrichment with quantitative mass spectrometry-based proteomics. Here, we report a robust and proteome-wide approach for the exploration of five major classes of protein lipidation in living cells, through the use of specific chemical probes for each lipid PTM. In-cell labeling of lipidated proteins is achieved by the metabolic incorporation of a lipid probe that mimics the specific natural lipid, concomitantly wielding an alkyne as a bio-orthogonal labeling tag. After incorporation, the chemically tagged proteins can be coupled to multifunctional 'capture reagents' by using click chemistry, allowing in-gel fluorescence visualization or enrichment via affinity handles for quantitative chemical proteomics based on label-free quantification (LFQ) or tandem mass-tag (TMT) approaches. In this protocol, we describe the application of lipid probes for N-myristoylation, N- and S-acylation, O-cholesterylation, S-farnesylation and S-geranylgeranylation in multiple cell lines to illustrate both the workflow and data obtained in these experiments. We provide detailed workflows for method optimization, sample preparation for chemical proteomics and data processing. A properly trained researcher (e.g., technician, graduate student or postdoc) can complete all steps from optimizing metabolic labeling to data processing within 3 weeks. This protocol enables sensitive and quantitative analysis of lipidated proteins at a proteome-wide scale at native expression levels, which is critical to understanding the role of lipid PTMs in health and disease.

Multiple sequence alignment of homoserine-acetyltransferases, serine-acetyltransferases and homoserine-succinyltransferases show they all belong to MetX family, having evolved from a common ancestor by conserving the catalytic site and substrate binding residues. The discrimination in the substrate selection arises due to the presence of substrate-specific residues lining the substrate-binding pocket. Mutation of Ala59 and Gly62 to Gly and Pro respectively in homoserine-acetyltransferase from M. tuberculosis resulted in a serine-acetyltransferase like enzyme as it acetylated both l -homoserine and l -serine. Homoserine-acetyltransferase from M. tuberculosis when mutated at positon 322 where Leu was converted to Arg, resulted in succinylation over acetylation of l -homoserine. Our studies establish the importance of the substrate binding residues in determining the type of activity possessed by MetX family, despite all of them having the same catalytic triad Ser-Asp-His. Hence key residues at the substrate binding pocket dictate whether the given enzyme shows predominant transferase or hydrolase activity.

Purpose Phosphatidylinositol Glycan Anchor Biosynthesis, class G (PIGG) is an ethanolamine phosphate transferase catalyzing the modification of glycosylphosphatidylinositol (GPI). GPI serves as an anchor on the cell membrane for surface proteins called GPI-anchored proteins (GPI-APs). Pathogenic variants in genes involved in the biosynthesis of GPI cause inherited GPI deficiency (IGD), which still needs to be further characterized. Methods We describe 22 individuals from 19 unrelated families with biallelic variants in PIGG. We analyzed GPI-AP surface levels on granulocytes and fibroblasts for three and two individuals, respectively. We demonstrated enzymatic activity defects for PIGG variants in vitro in a PIGG/PIGO double knockout system. Results Phenotypic analysis of reported individuals reveals shared PIGG deficiency–associated features. All tested GPI-APs were unchanged on granulocytes whereas CD73 level in fibroblasts was decreased. In addition to classic IGD symptoms such as hypotonia, intellectual disability/developmental delay (ID/DD), and seizures, individuals with PIGG variants of null or severely decreased activity showed cerebellar atrophy, various neurological manifestations, and mitochondrial dysfunction, a feature increasingly recognized in IGDs. Individuals with mildly decreased activity showed autism spectrum disorder. Conclusion This in vitro system is a useful method to validate the pathogenicity of variants in PIGG and to study PIGG physiological functions. Unlabelled Image

Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) is a nucleotide sugar used by glycosyltransferases to synthesize glycoproteins, glycosaminoglycans, glycolipids, and glycoRNA. UDP-GlcNAc also serves as the donor substrate for forming O-GlcNAc, a dynamic intracellular protein modification involved in diverse signaling and disease processes. UDP-GlcNAc is thus a central metabolite connecting nutrition, metabolism, signaling, and disease. There is a great interest in monitoring UDP-GlcNAc in biological systems. Here, we present the first genetically encoded, green fluorescent UDP-GlcNAc sensor (UGAcS), an optimized insertion of a circularly permuted green fluorescent protein (cpGFP) into an inactive mutant of an Escherichia coli UDP-GlcNAc transferase, for ratiometric monitoring of UDP-GlcNAc dynamics in live mammalian cells. Although UGAcS responds to UDP-GlcNAc quite selectively among various nucleotide sugars, UDP and uridine triphosphate (UTP) interfere with the response. We thus developed another biosensor named UXPS, which is responsive to UDP and UTP but not UDP-GlcNAc. We demonstrated the use of the biosensors to follow UDP-GlcNAc levels in cultured mammalian cells perturbed with nutritional changes, pharmacological inhibition, and knockdown or overexpression of key enzymes in the UDP-GlcNAc synthesis pathway. We further utilized the biosensors to monitor UDP-GlcNAc concentrations in pancreatic MIN6 β-cells under various culture conditions., Novel fluorescent-protein-based biosensors are developed to enable live-cell monitoring of UDP-GlcNAc, a key nucleotide sugar connecting nutrition, metabolism, signaling, and disease.

Poly(ADP-ribosyl) polymerase-1(PARP-1) is an abundant ADP-ribosyl transferase that regulates various biological processes. PARP-1 is widely recognized as a first-line responder molecule in DNA damage response (DDR). Here, we review the full cycle of detecting the DNA damage by PARP-1, PARP-1 activation upon DNA binding, and PARP-1 release from DNA break. We also discuss the allosteric consequence upon binding of PARP inhibitors (PARPi) and the opportunity to tune its release from a DNA break. It is now possible to harness this new understanding to design novel PARPi for treating diseases where cell toxicity caused by PARP-1 “trapping” on DNA is either the desired consequence or entirely counterproductive.

Xenobiotic nucleic acids (XNAs) offer tremendous potential for synthetic biology, biotechnology, and molecular medicine but their ability to mimic nucleic acids still needs to be explored. Here, to study the ability of XNA oligonucleotides to mimic tRNA, we synthesized three L-Ala-tXNAs analogs. These molecules were used in a non-ribosomal peptide synthesis involving a bacterial Fem transferase. We compared the ability of this enzyme to use amino-acyl tXNAs containing 1',5'-anhydrohexitol (HNA), 2'-fluoro ribose (2'F-RNA) and 2'-fluoro arabinose. L-Ala-tXNA containing HNA or 2'F-RNA were substrates of the Fem enzyme. The synthesis of peptidyl-XNA and the resolution of their structures in complex with the enzyme show the impact of the XNA on protein binding. For the first time we describe functional tXNA in an in vitro assay. These results invite to test tXNA also as substitute for tRNA in translation. ispartof: NUCLEIC ACIDS RESEARCH vol:50 issue:20 pages:11415-11425 ispartof: location:England status: published

Background : Hepatic fibrosis results from various chronic insults such as chronic hepatitis B and C, parasitic disease, autoimmune hepatitis, nonalcoholic steatohepatitis (NASH) and hereditary metal over load e.g. iron and cupper and it is linked with remarkable morbidity and mortality Aim: T o evaluate and compare the antifibrotic effect of Aqueous Garlic extract and Licorice Aqueous extract on carbon tetrachloride induced hepatic fibrosis in rats. Method: 4 groups of rats were taken. In group A and group B, rats were given injection of normal saline intraperitonally. In group C and D, rats were given injection of Aqueous garlic extract (AGE) and licorice aqueous extract (LAE) 01 ml / Kg body weight of rat /day intraperitonally for next four weeks respectively. At the end, all rats were sacrificed. Blood and liver were taken for biochemical examination. Results : This study results showed that the use of aqueous garlic extract and aqueous licorice extract reduces CCl4 induced liver fibrosis in rats. Keywords: Aqueous garlic extract (AGE), licorice aqueous extract (LAE), hepatic fibrosis, anti-fibrotic effect

Antimicrobial peptides harboring S- and or O-linked glycans are known as glycocins. Glycocins were first discovered and best characterized in Firmicutes. S-glycosylation is an enzymatic process catalyzed by S-glycosyltransferases of the GT2 family. Using a heterologous expression system, here we describe an inverting S/O-HexNAc-transferase (SvGT), encoded by ORF AQF52_3101 of Streptomyces venezuelae ATCC 15439, along with its acceptor substrate (SvC), encoded by ORF AQF52_3099. Using in vitro and in vivo assays, we define the distinct donor specificity, acceptor specificity, regioselectivity, chemoselectivity and Y(G/A/K/Q/E ≠ ΔG)(C/S/T ≠ Y/N)(G/A ≠ P/Q)G as the minimum acceptor sequon of SvGT. Although UDP-GlcNAc served as the donor in the cellular milieu, SvGT could also utilize UDP-Glc and UDP-GalNAc as donors in vitro. Using mass spectrometry and western blotting, we provide evidence that an anti-O-GlcNAc antibody (CTD110.6) cross-reacts with S-GlcNAc and may be used to detect S-GlcNAcylated glycoconjugates directly. With an understanding of enzyme specificities, we finally employed SvGT to generate two proof-of-concept neoglycocins against Listeria monocytogenes. In conclusion, this study provides the first experimental evidence for S-glycosylation in Actinobacteria and the application of its S/O-HexNAc-transferase in glycocin engineering.

Site-specific protein labeling methods are highly valuable tools for research and applications. We present a new protein labeling method that allows covalent attachment of a chromo-and fluorogenic flavin (FMN) to any targeted protein using a short flavinylation peptide-Tag. We show that this peptide can be as short as 7 residues and can be located at the N-Terminus, C-Terminus, or in internal regions of the target protein. Analogous to kinase-catalyzed phosphorylation, the flavin is covalently attached via a stable phosphothreonyl linkage. The site-specific covalent tethering of FMN is accomplished by using a bacterial flavin transferase. The covalent coupling of FMN was shown to work in Escherichia coli and Saccharomyces cerevisiae cells and could be performed in vitro, rendering the "Flavin-Tag"method a powerful tool for the selective decoration of proteins with a biocompatible redox-Active fluorescent chromophore.

A new series of quinolone-thiazolidinone hybrid molecules 8a-o were prepared. Quinoline compounds were synthesized by Meth-Cohn synthesis and were condensed with 2,3-disubstituted thiazolidinone. These molecules were screened for their anticancer activities against MDA-MB-231 and MCF-7 cell line using MTT assay. Potent compounds were tested for their cytotoxicity on normal HEK 293 cell lines and most potent compound was tested for its cell cycle analysis. Molecular docking and molecular dynamic studies were performed on human N-acetyl transferase (hNAT-1) protein using Schrodinger molecular docking toolkit. Compound 8n emerged as potent with IC50 8.16 µM against MDA-MB-231 cell line followed by 8e with IC50 17.68 µM. Compound 8n arrested cell cycle at G2/M phase and was non-toxic to human normal kidney cell line. The potent compound 8n binds well with human NAT-1 protein with remarkable hydrogen bonding and π–π interactions. Molecular dynamic studies of 8n further confirm the target for these molecules. Target quinolinone-thiazolidinones were found to be new class of compounds targeting hNAT-1 and can serve as new lead compounds in drug discovery.

The catalytic subunit of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) contains two active sites that catalyze nucleotidyl-monophosphate transfer (NMPylation). Mechanistic studies and drug discovery have focused on RNA synthesis by the highly conserved RdRp. The second active site, which resides in a Nidovirus RdRp-Associated Nucleotidyl transferase (NiRAN) domain, is poorly characterized, but both catalytic reactions are essential for viral replication. One study showed that NiRAN transfers NMP to the first residue of RNA-binding protein nsp9; another reported a structure of nsp9 containing two additional N-terminal residues bound to the NiRAN active site but observed NMP transfer to RNA instead. We show that SARS-CoV-2 RdRp NMPylates the native but not the extended nsp9. Substitutions of the invariant NiRAN residues abolish NMPylation, whereas substitution of a catalytic RdRp Asp residue does not. NMPylation can utilize diverse nucleotide triphosphates, including remdesivir triphosphate, is reversible in the presence of pyrophosphate, and is inhibited by nucleotide analogs and bisphosphonates, suggesting a path for rational design of NiRAN inhibitors. We reconcile these and existing findings using a new model in which nsp9 remodels both active sites to alternately support initiation of RNA synthesis by RdRp or subsequent capping of the product RNA by the NiRAN domain., Graphical Abstract Graphical AbstractCoronaviral RNA polymerase uses nucleoside triphosphates to make RNA and modify proteins, fueling viral replication. Acting as direct inhibitors or alternative substrates, nucleotide analogs can thwart SARS-CoV-2 and other viruses.

Background: The fish pathogen Aeromonas hydrophila is fast acquiring resistance to commonly employed antibiotics in aquaculture. This development has compelled the aquaculture sector to identify and develop new therapeutics to manage the pathogen. Methods: In this study, the protein 3-deoxy-d-manno-2-octulosonic acid (Kdo) transferase of A. hydrophila involved in the biosynthesis of the cell wall was studied in-silico as a potential drug target to control this pathogen. The three-dimensional structure of Kdo transferase was predicted by homology modelling using the Modellar 9.15. A total of 7682 natural compounds and 55 known Gram-negative bacterial inhibitors were virtually screened. Laboratory evaluation of inhibitory effects of identified inhibitors against A. hydrophila was performed using extracts from tea leaves and Astragalus by standard disc diffusion method. Results: A molecular model of putative virulence factor Kdo was derived by homology modelling. Eleven compounds were found to be potential inhibitors of Kdo. Among natural compounds, LArabinose and Flavan-3,4-diol were identified as the putative therapeutic agents. In the disc diffusion test, the zones of inhibition were observed at 2 mg/ml concentrations for tea leaves extracts and 8 mg/ml for Astragalus, suggesting the inhibitory effects of these extracts. Conclusion: The study shows the utility of essential enzymes such as the protein Kdo transferase as a putative drug target and the potential application of natural compounds in the control of pathogens in aquaculture without the need to use synthetic antimicrobial compounds.

Small-angle X-ray scattering and tryptophan fluorescence studies of phospho­ethano­lamine transferase (EptA) suggest conformational flexibility linked to enzyme activity., Many pathogenic gram-negative bacteria have developed mechanisms to increase resistance to cationic antimicrobial peptides by modifying the lipid A moiety. One modification is the addition of phospho­ethano­lamine to lipid A by the enzyme phospho­ethano­lamine transferase (EptA). Previously we reported the structure of EptA from Neisseria, revealing a two-domain architecture consisting of a periplasmic facing soluble domain and a transmembrane domain, linked together by a bridging helix. Here, the conformational flexibility of EptA in different detergent environments is probed by solution scattering and intrinsic fluorescence-quenching studies. The solution scattering studies reveal the enzyme in a more compact state with the two domains positioned close together in an n-do­decyl-β-d-maltoside micelle environment and an open extended structure in an n-do­decyl-phospho­choline micelle environment. Intrinsic fluorescence quenching studies localize the domain movements to the bridging helix. These results provide important insights into substrate binding and the molecular mechanism of endotoxin modification by EptA.

A novel cell-free biosynthesis system based on a mixture of chassis cell extracts and purified Spy-cyclized enzymes (CFBS-mixture) was developed. As a demonstration, the CFBS-mixture was applied to chlorogenic acid (CGA) biosynthesis. The mix-and-match and Plackett-Burman experiments demonstrated that Lonicera japonica hydroxycinnamate-CoA quinate transferase and p-hydroxyphenylacetate 3-hydroxylase were the key enzymes for the production of CGA. After optimization of the concentrations of the biosynthetic enzymes in the CFBS-mixture reaction using the Plackett-Burman experimental design and the path of the steepest ascent, 711.26 ± 15.63 mg/L CGA was produced after 16 h, which is 71.1-fold the yield obtained using the conventional crude extract-based CFBS and 9.1-fold the reported yield obtained using the living cells. Based on the CFBS-mixture results, the production of CGA was further enhanced in engineered Escherichia coli. The CFBS-mixture strategy is highly effective and will be useful for high-level CFBS of natural products.

Background: Hyperthyroidism is one of the most common endocrine disorders. Thyroid hormones are essential for normal metabolic function of body cells including the liver cells. Again, metabolism of thyroid hormones takes place in liver. Therefore, hyperthyroidism may affect liver cells and causes change in hepatic enzymes level. Objective: To assess serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels in hyperthyroid patients. Methods: This cross sectional study was conducted in the Department of Physiology of Dhaka Medical College from July 2016 to June 2017. Total number of 50 subjects of both sexes aged from 18 to 50 years were selected. Among them, 25 hyperthyroid patients were considered as the study group (B) and 25 age matched healthy subject were considered as control group (A). Serum ALT and ALP were estimated in the Biochemistry & Molecular Biology Department of BSMMU. For statistical analysis, Unpaired student’s ‘t’ test and Chi Square test were done. Results: Serum ALT and ALP levels were significantly (p

Background: People with type2 diabetes mellitus (DM) are at amplified chance of non-alcoholic fatty liver disease. Objective: To observe the effects of omega-3 fatty acid supplementation Alanine Transferase (ALT) and Aspartate Transferase (AST) in middle age patients with type 2 DM. Methods: A prospective interventional study in 2017, recruited 52 type 2 diabetic patients of both sexes aged 40 to 50 years. Among them, 27 patients were given fish oil capsule orally (omega 3 fatty acid 2g/day) for consecutive 12 weeks and 25 patients without supplementation were selected as control also studied after 12 weeks. Serum ALT and AST of all patients were estimated by enzymatic colorimetric method at baseline and after 12 weeks. For statistical analysis, Paired Student’s ‘t’ test and Unpaired Student’s ‘t’ test were performed. Results: In this study ALT and AST significantly decreased in patients supplemented with omega-3 fatty acid after 12 weeks, ALT (alanine aminotransferase) and AST (aspartate transaminase) were decreased in diabetic patients after supplementation with omega- 3 fatty acid in comparison to control group. Conclusion: It can be concluded that omega-3 fatty acid supplementation was effective to reduce ALT and AST levels in diabetic patients and it may be helpful to minimize the risk of fatty liver in type-2 DM. J Bngladesh Soc Physiol 2021;16(1): 39-43

Antiphagocytic capsular polysaccharides are key components of effective vaccines against pathogenic bacteria. Neisseria meningitidis groups B and C, as well as Escherichia coli serogroups K1 and K92, are coated with polysialic acid capsules. Although the chemical structure of these polysaccharides and the organization of the associated gene clusters have been described for many years, only recently have the details of the biosynthetic pathways been discovered. The polysialic acid chains are synthesized by polysialyltransferases on a proposed phosphatidylglycerol lipid acceptor with a poly keto-deoxyoctulosonate (KDO) linker. Synthesis of this acceptor requires at least three enzymes in E. coli K1: KpsS, KpsC, and NeuE. In this report, we have characterized the β-KDO glycosyltransferase KpsS, the first enzyme in the pathway for lipid acceptor synthesis. After purification of KpsS in a soluble active form, we investigated its function and substrate specificity and showed that KpsS can transfer a KDO residue to a fluorescently labeled phosphatidylglycerol lipid. The enzyme tolerated various lengths of fatty acid acyl chains on the phosphatidylglycerol, including fluorescent tags, but exhibited a preference for phosphatidylglycerol diacylated with longer fatty acid chains as indicated by the smaller Kd and Km values for substrates with chains with more than 14 members. Additional structural analysis of the KpsS product confirmed that KpsS transfers KDO from CMP-KDO to the 1-hydroxyl of phosphatidylglycerol to form a β-KDO linkage.